Pith. sign in

REVIEW 4 major objections 4 minor 4 cited by

Exploring the Interplay of Adiposity, Ethnicity, and Hormone Receptor Profiles in Breast Cancer Subtypes

T0 review · 4 major / 4 minor · reviewed 2026-08-06 · deepseek-v4-flash

Challenge this review Re-run · record.json Download PDF Read on arXiv ↗

Pith's one-line read The paper claims that higher BMI and Black/African American race independently raise the odds of the aggressive Luminal B breast cancer subtype over the indolent Luminal A, and that obesity partially explains the racial gap.

desk verdict Synthetic data, a figure/table contradiction, and a copied conclusion make this paper a desk reject. read the letter →

arxiv 2507.21348 v1 pith:XE6QR2F7 submitted 2025-07-28 q-bio.QM stat.AP

Izabel Valdez , Paramahansa Pramanik This is my paper
classification q-bio.QMstat.AP MSC 62P1062J1262F40
keywords breastcancerLuminalBsubtypeobesitybodymassindexracialdisparitieslogisticregressioncausalmediationanalysissyntheticdata
verification ladder T0 review T1 audit T2 compute T3 formal

The pith

A machine-rendered reading of the paper's core claim, the machinery that carries it, and where it could break.

The reading

This paper sets out to determine whether obesity and race jointly shape the risk of Luminal B versus Luminal A breast cancer, the two most common hormone-receptor-positive subtypes. Using multivariable logistic regression and causal mediation analysis on a synthetic dataset built to preserve the properties of the FLEX breast cancer registry, it argues that each one-point increase in BMI raises the odds of Luminal B by about 5%, and that Black/African American women have roughly 1.7 times the odds of Luminal B even after BMI, age, menopausal status, and stage are taken into account. It further claims that BMI is a statistically significant partial mediator of the race–Luminal B association. The stakes are clinical and social: distinguishing the more aggressive Luminal B from the indolent Luminal A could sharpen screening and weight-management guidance, especially for postmenopausal and Black women.

What carries the argument

The argument is carried by two statistical objects. The first is the multivariable logistic regression model $$\log \frac{P(Y=1)}{1-P(Y=1)} = \beta_0 + \beta_1\text{BMI} + \beta_2\text{Age} + \beta_3\text{Race}_{\text{Black}} + \beta_4\text{Menopause} + \beta_5\text{Stage},$$ which converts each predictor into an odds ratio for Luminal B versus Luminal A. The second is the causal mediation analysis: a mediator model regressing BMI on Black race, an outcome model regressing Luminal B status on race and BMI together, and a Sobel test plus nonparametric bootstrap (1000 replications) for the indirect effect, with a sensitivity parameter $\rho$ for unmeasured confounding. This machinery lets the paper separate the direct racial effect from the indirect pathway running through BMI, and it is the formal mediation test that the authors present as the study's distinctive contribution.

What would settle it

Reproduce the analysis from the paper's own appendix code and from the real FLEX registry: the appendix simulates n = 3000 with 15% Black patients, whereas Table 1 reports 3540 patients with 7.7% Black, and the code's 45% base rate would not yield the tabulated 1610 Luminal B cases. If the synthetic data cannot reproduce Table 1's counts or Table 2's positive BMI odds ratio—which also contradicts Figure 1's decreasing Luminal B probability with BMI—then the reported associations are simulation artifacts rather than registry findings. A check of whether the coefficients were computed on raw BMI (per-unit OR 1.05) or on the standardized BMI the methods say was used would settle the direction and size of the BMI effect.

Watch

Extended reading notes

Core claim

The central claim is that both adiposity and race are significant, independent predictors of Luminal B as opposed to Luminal A breast cancer. In the analyzed data, the odds ratio for Luminal B is 1.05 per unit BMI (95% CI 1.03–1.07) and 1.69 for Black/African American versus White women (95% CI 1.28–2.12), with younger age, premenopausal status, and later stage also associated with Luminal B. The causal mediation analysis reports an indirect effect of race through BMI of 0.089 (Sobel p = 0.018), which the authors interpret as obesity partially mediating the higher Luminal B risk in Black women, while a substantial direct racial effect remains. Subgroup models show the BMI effect is larger in postmenopausal women, consistent with adipose tissue becoming the dominant estrogen source after menopause, while the race coefficient is somewhat larger in premenopausal women.

Load-bearing premise

The whole analysis rests on the assumption that the synthetic dataset augmented from the FLEX registry faithfully reproduces the real registry population; if the simulated patients do not match actual FLEX patients, every reported odds ratio and mediation effect is an artifact of the simulation choices.

Editorial extensions

If this is right

  • If the results hold, a woman's BMI and race are usable, cheaply measured inputs for distinguishing who is more likely to have Luminal B rather than Luminal A, with consequences for how aggressively her tumor is treated.
  • Weight control becomes a targeted lever: the stronger BMI effect in postmenopausal women implies that weight-management programs would yield the largest Luminal B risk reduction in that group.
  • Because the direct racial effect remains large after accounting for BMI, closing the Luminal B gap requires interventions on healthcare access, screening timeliness, and structural barriers, not weight loss alone.
  • The significant mediation path implies that part of the racial disparity is biologically embodied through adiposity, so obesity reduction in Black communities should narrow—though not erase—the subtype disparity.
  • Stage II or higher diagnosis being associated with Luminal B suggests that aggressive-subtype tumors present later, reinforcing the case for earlier screening in high-risk groups.

Reading between the lines

Editorial extensions of the paper, not claims the author makes directly.

  • The paper's own numbers imply that BMI is a minor mediator: the indirect effect (0.089) is about a fifth the size of the direct effect (0.441), so even eliminating the Black–White BMI gap would remove only a small slice of the Luminal B disparity; the majority would remain tied to the unmeasured social and healthcare factors the paper discusses qualitatively.
  • A testable extension the authors hint at but do not perform: if BMI histories were available for the full cohort, the slope of weight gain rather than a single BMI reading might be the stronger, and more actionable, predictor of Luminal B; their exploratory finding on pre-diagnosis weight gain predicts exactly this.
  • Editorial note: the concluding section describes a survival analysis of the Carolina Breast Cancer Study using Bayesian methods and random survival forests that does not match the abstract's logistic-regression and mediation design; the abstract and results tables are the coherent statement of this paper's contribution.
Share X Bluesky LinkedIn Reddit HN

Editorial analysis

A structured set of objections, weighed in public.

Desk editor's note, referee report, and a circularity audit.

Referee Report

4 major / 4 minor

Summary. The paper investigates whether body mass index (BMI) and race predict the Luminal B versus Luminal A breast cancer subtype, using multivariable logistic regression and causal mediation analysis. The authors report that higher BMI (OR 1.05, 95% CI 1.03–1.07) and Black/African American race (OR 1.69, 95% CI 1.28–2.12) are significantly associated with Luminal B, and that BMI partially mediates the race–subtype relationship (indirect effect 0.089, Sobel p=0.018). The paper claims to use data from the FLEX registry with synthetic augmentation, and it includes an appendix with R code that simulates a SEER-like dataset. I assess the manuscript as not publishable in its current form: the data provenance is not credible, the reported results are internally inconsistent, and a substantial portion of the text appears to be unrelated to the presented analysis.

Significance. If the findings were supported by verifiable real-world data, they would be of clear clinical and public-health relevance, as they address the joint influence of obesity and race on aggressive Luminal B breast cancer and propose targeted screening and policy interventions. The use of mediation analysis to quantify whether obesity explains part of the racial disparity is methodologically appropriate and could inform future work. However, the significance cannot be assessed substantively because the empirical results are not traceable to any real dataset: the only reproducible code generates synthetic data with predictors that are independent of the outcome, and the manuscript contains no analysis script or data that would reproduce the reported tables. The internal contradiction between the positive BMI odds ratio and the downward-sloping probability curves in Figure 1 further undermines confidence in the results. Thus, the claimed contributions are currently unsupported.

major comments (4)
  1. [Section 2.1 and Appendix] The data provenance is not credible. Section 2.1 states that the analysis uses FLEX registry data with synthetic augmentation that preserves the original data's properties, but the only reproducible analysis in the Appendix is R code that simulates an unrelated SEER-like dataset with hand-set parameters (n = 3000, BMI ~ N(29.5, 6.5), race probabilities c(0.65, 0.15, 0.10, 0.05, 0.05)) and samples luminal_subtype independently of BMI and race. Under this data-generating process, the true coefficients for BMI and race in the logistic model are zero, yet Table 2 reports OR 1.05 for BMI and OR 1.69 for Black race. No code or data is provided that would reproduce the reported results, so the central findings are unverifiable and appear to be artifacts of undocumented simulation choices.
  2. [Figure 1 and Table 2] There is a direct internal contradiction between the reported BMI effect and the predicted-probability curves. Table 2 reports a positive BMI coefficient of 0.049 (OR 1.05, 95% CI 1.03–1.07), while Figure 1's caption and the accompanying text state that the predicted probability of Luminal B consistently decreases as BMI increases across all racial groups. A positive coefficient cannot produce monotonically decreasing probability curves. This is not a labeling issue; it indicates that either Figure 1 or Table 2 was generated from a different model or dataset, and it makes the central positive BMI finding irreproducible from the paper's own materials.
  3. [Section 6 (Conclusion)] The Conclusion is not a conclusion of this manuscript. It discusses the Carolina Breast Cancer Study (CBCS), SEER survival trends, Bayesian hierarchical models, random survival forests, DeepSurv, and survival disparities in basal-like/triple-negative breast cancer. None of these analyses appear in Sections 2–5, which focus solely on logistic regression and mediation analysis of Luminal A versus Luminal B subtype risk. As written, this section is an unrelated survival-analysis summary and cannot serve as the concluding discussion of the presented study.
  4. [Section 3.2 and Table 3] The mediation analysis is not reproducible from the provided materials. Section 3.2 states that causal mediation was performed with the mediation package using 1000 bootstrap replications and a sensitivity analysis based on ρ, but the Appendix contains only a simple logistic-regression fit on simulated independent data. No code, output, or sensitivity results are reported for the mediator model, outcome model, or bootstrap confidence intervals. Table 3's indirect effect (0.089) and Sobel p-value (0.018) are inconsistent with a simulated dataset in which luminal_subtype is independent of BMI and race, and the paper provides no evidence that these estimates came from any real analysis.
minor comments (4)
  1. [Section 5] The paragraph discussing historical BMI data mentions that 'we managed to pull some historical BMI info from about 20% of the cases covering the five years before the diagnosis,' but no details are given on how this subsample was obtained, how missingness was handled, or how the longitudinal analysis was performed; this is an unsubstantiated post-hoc claim.
  2. [Throughout] There are multiple typographical and grammatical errors, including 'we ca not say for sure' (Section 5), 'Soltutions must be taken' (Section 1.1.2), 'undeserved populations' (Section 1.2, should be 'underserved'), 'usingdplyr' (Section 3.3, missing space), and 'is performed' (Section 3.1, subject-verb agreement). The manuscript would benefit from careful proofreading.
  3. [Figure 2] Figure 2 is placed without an explicit in-text reference in the results section; it appears in the Discussion without a clear description of how the density plot was constructed or what statistical test, if any, supports the claim of a 'marginally higher BMI trend' for Luminal B.
  4. [References] The reference list includes numerous self-citations to unrelated works (e.g., Pramanik (2016), Pramanik and Polansky (2020), Pramanik (2021a)) that do not appear to inform the breast cancer analysis; the authors should cite only relevant literature.

Circularity Check

2 steps flagged · score 8.0 of 10

The paper's central 'findings' are generated by its own simulation code, whose inputs set the outcome independently of BMI; Figure 1 and Table 2 contradict each other, and Table 2 is not reproducible from the provided materials.

  1. fitted input called prediction [Appendix, 'Simulation and Prediction in R'; Section 2.1, 'Data Source and Study Design']
    "# Simulate SEER-like data ... luminal_subtype = sample(c('A','B'), n, replace = TRUE, prob = c(0.55, 0.45)), BMI = rnorm(n, 29.5, 6.5), ... model <- glm(luminal_subtype_bin ~ BMI + race + menopause + age, data = data, family = 'binomial')"

    The outcome is sampled independently of BMI and race, so the fitted model's BMI coefficient and the predicted-probability curves in Figure 1 are determined by the random seed and the chosen sampling probabilities, not by any real association. The paper presents a BMI OR of 1.05 and a Black/African American race OR of 1.69 as findings; if these come from this pipeline, they are equivalent by construction to the simulation inputs, which contain no BMI effect and an arbitrary race composition.

  2. other [Figure 1 caption and Section 4.1 text; Table 2]
    "Figure 1 caption: 'Logistic regression shows a consistent decrease in Luminal B subtype likelihood with increasing BMI across all racial groups.' Table 2 text: 'each extra point in BMI is linked to a 5% higher chance of having the Luminal B subtype.'"

    The paper's own display and narrative contradict its central numerical result: Figure 1 says the probability of Luminal B decreases with BMI, while Table 2 reports a positive odds ratio of 1.05. The only reproducible code in the Appendix generates decreasing or flat curves, so Table 2's positive coefficient is not reproducible from the paper's materials. This internal contradiction means at least one of the reported 'findings' is an artifact of an unshown analysis choice, and the claimed prediction is not a self-contained derivation from data.

full rationale

The paper's derivation chain is not self-contained. Section 2.1 claims data from the FLEX registry with synthetic augmentation, but the only reproducible code in the Appendix simulates a SEER-like dataset in which luminal_subtype is sampled independently of BMI and race. The 'predicted probability' curves in Figure 1 are therefore direct outputs of that simulation and carry no evidential weight; the negative slope shown is an artifact of the random seed and the chosen sampling probabilities. Table 2's positive BMI OR (1.05) and Black race OR (1.69) cannot be reproduced from the provided code and flatly contradict Figure 1 and the accompanying text. No FLEX data file, no augmentation code, and no script that produces Table 2 are provided, so the central associations reduce to simulation inputs rather than to empirical evidence. The mediation table is arithmetically coherent (the indirect effect is the product of the path coefficients), but it inherits the same data-provenance problem. The paper thus exhibits a central 'prediction' that is forced by construction from the authors' own simulation choices, warranting a high circularity score.

Assumptions & free parameters 6 free parameters · 4 assumptions · 1 invented entities

The central claims rest entirely on simulated data generated by the Appendix R code. The simulation's hand-chosen parameters (sample size, distribution means, race probabilities) directly determine the reported odds ratios and mediation effects. No real data, code repository, or external validation is provided.

free parameters (6)
  • Simulation sample size n = 3000
    Set in Appendix R code; determines precision of all reported estimates.
  • Simulation BMI mean and SD = mean 29.5, SD 6.5
    Chosen by hand in Appendix; directly shapes BMI-subtype association.
  • Simulation race distribution = White 0.65, Black 0.15, Hispanic 0.10, Asian 0.05, Other 0.05
    Chosen by hand; determines racial group sizes and the Black OR.
  • Simulation Luminal subtype prevalence = A 0.55, B 0.45
    Chosen by hand; affects baseline odds and power.
  • Simulation age distribution = mean 61, SD 12
    Chosen by hand; affects age adjustment.
  • Simulation menopausal probability = 0.7 postmenopausal
    Chosen by hand; affects menopause coefficient.
assumptions (4)
  • domain assumption FLEX registry contains the described cohort
    Stated in Section 2.1, but no access details or registry citation given.
  • ad hoc to paper Synthetic data augmentation preserves original data properties
    Claimed in Section 2.1; no validation shown; the Appendix simulates data instead.
  • domain assumption Causal mediation assumptions hold (no unmeasured confounding)
    Section 3.2 uses mediation package; sensitivity analysis for rho is mentioned but results not reported.
  • standard math Logistic regression model is correctly specified
    Standard modeling assumption, but the Figure 1 contradiction suggests misspecification or coding error.
invented entities (1)
  • Synthetic patient data
    purpose: Substitute for real FLEX registry data in all analyses
    The paper's only reproducible artifact is a data simulation; no real patient data is provided, so the 'study population' is an invention of the authors.

how reviews work

0 comments
Cite this review

Pith. "Pith review of Exploring the Interplay of Adiposity, Ethnicity, and Hormone Receptor Profiles in Breast Cancer Subtypes." pith.science (2026). https://pith.science/paper/XE6QR2F7

@misc{pith2026250721348,
  author       = {Pith},
  title        = {Pith review of: Exploring the Interplay of Adiposity, Ethnicity, and Hormone Receptor Profiles in Breast Cancer Subtypes},
  year         = {2026},
  howpublished = {\url{https://pith.science/paper/XE6QR2F7}},
  note         = {Machine review of arXiv:2507.21348}
}
read the original abstract

This study explores how obesity and race jointly influence the development and prognosis of Luminal subtypes of breast cancer, with a focus on distinguishing Luminal A from the more aggressive Luminal B tumors. Drawing on large-scale epidemiological data and employing statistical approaches such as logistic regression and mediation analysis, the research examines biological factors like estrogen metabolism, adipokines, and chronic inflammation alongside social determinants including healthcare access, socioeconomic status, and cultural attitudes toward body weight. The findings reveal that both obesity and racial background are significant predictors of risk for Luminal B breast cancers. The study highlights the need for a dual approach that combines medical treatment with targeted social interventions aimed at reducing disparities. These insights can improve individualized risk assessments, guide tailored screening programs, and support policies that address the heightened cancer burden experienced by marginalized communities.

Figures

Figures reproduced from arXiv: 2507.21348 by the authors.

Figure 1
Figure 1. Predicted Probability of Luminal B Subtype by BMI and Race. Logistic regression [PITH_FULL_IMAGE:figures/full_fig_p012_1.png] view at source ↗
Figure 2
Figure 2. Distribution of BMI by Luminal Subtype. This density plot shows the distribution [PITH_FULL_IMAGE:figures/full_fig_p017_2.png] view at source ↗

Discussion (0). Sign in to comment.

Forward citations

Cited by 4 Pith papers

Reviewed papers in the Pith corpus that reference this work. Sorted by Pith novelty score.

  1. Modeling Educational Performance Using School Demographics and Teacher Characteristics

    stat.ME 2026-06 unverdicted novelty 6.0 of 10

    Introduces Adaptive Weighted Group Fused LASSO estimator with ADMM algorithm and asymptotic guarantees, demonstrated on Alabama school math proficiency data.

  2. Obesity and Sociodemographic Factors in Luminal Breast Cancer

    q-bio.QM 2026-05 unverdicted novelty 3.0 of 10

    Higher BMI and African ancestry independently associate with Luminal B breast cancer, with BMI partially mediating the ancestry link in a cohort of 3,538 patients.

  3. Predictive Significance of CD276/B7-H3 Expression in Baseline Biopsies of Advanced Prostate Carcinoma

    q-bio.QM 2025-08 reject novelty 3.0 of 10

    High B7-H3 expression in initial prostate biopsy samples is associated with shorter survival and more aggressive disease in men with advanced prostate cancer.

  4. Optimal Harvesting under Stochastic Control: HJB Equation and Feynman-Kac Representation

    math.OC 2026-06 unverdicted novelty 2.0 of 10

    Applies standard HJB and Feynman-Kac methods to stochastic harvesting models and claims they are consistent for policy design.

Reference graph

Works this paper leans on

48 extracted references · 8 canonical work pages · cited by 4 Pith papers

  1. [1]

    D., Krieger, N., Agénor, M., Graves, J., Linos, N., and Bassett, M

    Bailey, Z. D., Krieger, N., Agénor, M., Graves, J., Linos, N., and Bassett, M. T. (2017). Structural racism and health inequities in the usa: evidence and interventions. The Lancet , 389(10077):1453--1463

    work page 2017

  2. [2]

    E., Finn, E., Sykora, P., Lynch, V

    Bulls, S. E., Finn, E., Sykora, P., Lynch, V. J., Pramanik, P., Glaberman, S., and Chiari, Y. (2025). Assessing cometchip technology for dna damage studies in non-model species: distinct uv-induced responses in turtles and mammals. BMC Research Notes , 18(1):1--7

    2025

  3. [3]

    A., Perou, C

    Carey, L. A., Perou, C. M., Livasy, C. A., Dressler, L. G., Cowan, D., Conway, K., Karaca, G., Troester, M. A., Tse, C. K., Edmiston, S., et al. (2006). Race, breast cancer subtypes, and survival in the carolina breast cancer study. Jama , 295(21):2492--2502

    work page 2006

  4. [4]

    A., Pramanik, P., Marbut, S

    Dasgupta, S., Acharya, S., Khan, M. A., Pramanik, P., Marbut, S. M., Yunus, F., Galeas, J. N., Singh, S., Singh, A. P., and Dasgupta, S. (2023). Frequent loss of cacna1c, a calcium voltage-gated channel subunit is associated with lung adenocarcinoma progression and poor prognosis. Cancer Research , 83(7\_Supplement):3318--3318

    2023

  5. [5]

    L., Vikramdeo, K

    Hertweck, K. L., Vikramdeo, K. S., Galeas, J. N., Marbut, S. M., Pramanik, P., Yunus, F., Singh, S., Singh, A. P., and Dasgupta, S. (2023). Clinicopathological significance of unraveling mitochondrial pathway alterations in non-small-cell lung cancer. The FASEB Journal , 37(7):e23018

    2023

  6. [6]

    Hua, L., Polansky, A., and Pramanik, P. (2019). Assessing bivariate tail non-exchangeable dependence. Statistics & Probability Letters , 155:108556

    2019

  7. [7]

    S., Oman, M., Patel, A

    Jackson, C. S., Oman, M., Patel, A. M., and Vega, K. J. (2020). Health disparities in colorectal cancer among racial and ethnic minorities in the united states. Journal of Gastrointestinal Oncology , 11(5):1031--1040

    work page 2020

  8. [8]

    P., Sarkar, C., and Chakroborty, D

    Kakkat, S., Pramanik, P., Singh, S., Singh, A. P., Sarkar, C., and Chakroborty, D. (2023). Cardiovascular complications in patients with prostate cancer: Potential molecular connections. International Journal of Molecular Sciences , 24(8):6984

    2023

Show all 48 references
  1. [9]

    A., Acharya, S., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J

    Khan, M. A., Acharya, S., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J. E., Dasgupta, S., and Singh, A. P. (2023). Myb exhibits racially disparate expression, clinicopathologic association, and predictive potential for biochemical recurrence in prostate...

    2023

  2. [10]

    A., Acharya, S., Kreitz, N., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J., Dasgupta, S., et al

    Khan, M. A., Acharya, S., Kreitz, N., Anand, S., Sameeta, F., Pramanik, P., Keel, C., Singh, S., Carter, J., Dasgupta, S., et al. (2024). Mp60-05 myb exhibits racially disparate expression and clinicopathologic association and is a promising predictor of biochemical recurrence...

    2024

  3. [11]

    Lauby-Secretan, B., Scoccianti, C., Loomis, D., Grosse, Y., Bianchini, F., and Straif, K. (2016). Body fatness and cancer—viewpoint of the iarc working group. New England Journal of Medicine , 375(8):794--798

    2016

  4. [12]

    Maki, E., Glimm, T., Pramanik, P., Chiari, Y., and Kiskowski, M. (2025). New approaches for capturing and estimating variation in complex animal color patterns from digital photographs: application to the eastern box turtle (terrapene carolina). PeerJ , 13:e19690

    2025

  5. [13]

    R., Kahathuduwa, C., Bolner, M

    Menikdiwela, K. R., Kahathuduwa, C., Bolner, M. L., Rahman, R. L., and Moustaid-Moussa, N. (2022). Association between obesity, race or ethnicity, and luminal subtypes of breast cancer. Biomedicines , 10(11):2931

    2022

  6. [14]

    M., Sørlie, T., Eisen, M

    Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., and Botstein, D. (2000). Molecular portraits of human breast tumours. Nature , 406(6797):747--752

    2000

  7. [15]

    Polansky, A. M. and Pramanik, P. (2021). A motif building process for simulating random networks. Computational Statistics & Data Analysis , 162:107263

    2021

  8. [16]

    Pramanik, P. (2016). Tail non-exchangeability . Northern Illinois University

    2016

  9. [17]

    Pramanik, P. (2020). Optimization of market stochastic dynamics. SN Operations Research Forum , 1(4):31

    2020

  10. [18]

    Pramanik, P. (2021a). Effects of water currents on fish migration through a feynman-type path integral approach under 8/3 liouville-like quantum gravity surfaces. Theory in Biosciences , 140(2):205--223

    2021

  11. [19]

    Pramanik, P. (2021b). Optimization of Dynamic Objective Functions Using Path Integrals . PhD thesis, Northern Illinois University

    2021

  12. [20]

    Pramanik, P. (2022a). On lock-down control of a pandemic model. arXiv preprint arXiv:2206.04248

    2022 arXiv

  13. [21]

    Pramanik, P. (2022b). Stochastic control of a sir model with non-linear incidence rate through euclidean path integral. arXiv preprint arXiv:2209.13733

    2022 arXiv

  14. [22]

    Pramanik, P. (2023a). Consensus as a nash equilibrium of a stochastic differential game. European Journal of Statistics , 3:10--10

    2023

  15. [23]

    Pramanik, P. (2023b). Optimal lock-down intensity: A stochastic pandemic control approach of path integral. Computational and Mathematical Biophysics , 11(1):20230110

    2023

  16. [24]

    Pramanik, P. (2023c). Path integral control in infectious disease modeling. arXiv preprint arXiv:2311.02113

    2023 arXiv

  17. [25]

    Pramanik, P. (2023d). Path integral control of a stochastic multi-risk sir pandemic model. Theory in Biosciences , pages 1--36

    2023

  18. [26]

    Pramanik, P. (2024a). Dependence on tail copula. J , 7(2):127--152

    2024

  19. [27]

    Pramanik, P. (2024b). Estimation of optimal lock-down and vaccination rate of a stochastic sir model: A mathematical approach. European Journal of Statistics , 4:3--3

    2024

  20. [28]

    Pramanik, P. (2024c). Measuring asymmetric tails under copula distributions. European Journal of Statistics , 4:7--7

    2024

  21. [29]

    Pramanik, P. (2024d). On estimation of function-on-function regression kernels with brownian berkson errors

    2024

  22. [30]

    Pramanik, P. (2024e). Stochastic control in determining a soccer player’s performance. J. Compr. Pure Appl. Math , 2:111

    2024

  23. [31]

    Pramanik, P. (2025a). An optimal level of stubbornness to win a soccer match. arXiv preprint arXiv:2501.18050

    2025 arXiv

  24. [32]

    Pramanik, P. (2025b). Stubbornness as control in professional soccer games: A bppsde approach. Mathematics , 13(3):475

    2025

  25. [33]

    L., and Ghanam, R

    Pramanik, P., Boone, E. L., and Ghanam, R. A. (2024). Parametric estimation in fractional stochastic differential equation. Stats , 7(3):745

    2024

  26. [34]

    and Dong, L

    Pramanik, P. and Dong, L. (2025a). Impact of random monetary shock: a keynesian case. arXiv preprint arXiv:2505.00800

    2025 arXiv

  27. [35]

    and Dong, L

    Pramanik, P. and Dong, L. (2025b). Strategic complementarities due to monetary shock under sticky price. European Journal of Statistics , 5:9--9

    2025

  28. [36]

    Pramanik, P., Graff, J., and Decaro, M. (2025a). On factors influencing consumer preference in pipeline stages: an experiment. arXiv preprint arXiv:2501.03418

    2025 arXiv

  29. [37]

    Pramanik, P., Graff, J., and Decaro, M. (2025b). Strategies to increase pipeline status: A case study from eclinical data. European Journal of Statistics , 5:3--3

    2025

  30. [38]

    and Maity, A

    Pramanik, P. and Maity, A. K. (2024). Bayes factor of zero inflated models under jeffereys prior. arXiv preprint arXiv:2401.03649

    2024 arXiv

  31. [39]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2020). Motivation to run in one-day cricket. arXiv preprint arXiv:2001.11099

    2020 arXiv

  32. [40]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2021). Optimal estimation of brownian penalized regression coefficients. arXiv preprint arXiv:2107.02291

    2021 arXiv

  33. [41]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023a). Optimization of a dynamic profit function using euclidean path integral. SN Business & Economics , 4(1):8

    2023

  34. [42]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023b). Scoring a goal optimally in a soccer game under liouville-like quantum gravity action. Operations Research Forum , 4(3):66

    2023

  35. [43]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2023c). Semicooperation under curved strategy spacetime. The Journal of Mathematical Sociology , pages 1--35

    2023

  36. [44]

    and Polansky, A

    Pramanik, P. and Polansky, A. M. (2024). Motivation to run in one-day cricket. Mathematics , 12(17):2739

    2024

  37. [45]

    S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J

    Prat, A., Parker, J. S., Karginova, O., Fan, C., Livasy, C., Herschkowitz, J. I., and Perou, C. M. (2010). Phenotypic and molecular characterization of the claudin-low intrinsic subtype of breast cancer. Breast Cancer Research , 13(6):R95

    2010

  38. [46]

    Vikramdeo, K., Anand, S., Sudan, S., Pramanik, P., Singh, S., Godwin, A., Singh, A., and Dasgupta, S. (2024a). Abstract po3-16-05: Mitochondrial dna mutation detection in tumors and circulating extracellular vesicles of triple negative breast cancer patients for biomarker deve...

    2024

  39. [47]

    Vikramdeo, K., Anand, S., Sudan, S., Pramanik, P., Singh, S., Godwin, A., Singh, A., and Dasgupta, S. (2024b). Mitochondrial dna mutation detection in tumors and circulating extracellular vesicles of triple negative breast cancer patients for biomarker development. In CANCER R...

    2024

  40. [48]

    S., Anand, S., Sudan, S

    Vikramdeo, K. S., Anand, S., Sudan, S. K., Pramanik, P., Singh, S., Godwin, A. K., Singh, A. P., and Dasgupta, S. (2023). Profiling mitochondrial dna mutations in tumors and circulating extracellular vesicles of triple-negative breast cancer patients for potential biomarker de...

    2023

Pith tools

Reviewed August 6, 2026 · model on record in the stance chip above.